Bharat Express

Insomnia May Increase Ovarian Cancer Risk, Experts Warn

Women suffering from insomnia may be at a significant risk of developing ovarian cancer, according to experts.


Women suffering from insomnia may be at a significant risk of developing ovarian cancer, according to experts.

Insomnia, a common sleep disorder that hinders falling asleep, staying asleep, or returning to sleep after waking too early, could have serious implications for women’s health.

Insomnia, often associated with stress and anxiety, may impact the risk and survival rates of ovarian cancer patients.

Dr. Kinjal Kothari of Manipal Hospital in Goa told IANS that research indicates disturbed sleep patterns can increase inflammation and weaken the immune system, potentially promoting cancer growth.

Insomnia Treatment’s Potential Impact

A recent study published in The Lancet highlights the impact of treating insomnia on survival rates in high-grade ovarian cancers.

The study suggests that addressing insomnia could not only improve survival rates but also potentially prevent the onset of ovarian cancer.

With cancer incidence and prevalence on the rise, there is an urgent need to study disease patterns and explore ways to enhance patient survival and quality of life.

As per IANS, Dr. Karthik K S of KMC Hospital in Mangalore stated that more than half of cancer patients suffer from sleep disorders, such as sleeplessness or abnormal sleep-wake cycles, significantly impacting their quality of life.

Dr. Karthik highlighted that alongside the physical challenges of cancer, such as pain and pressure symptoms, the psychological toll, including anxiety and depression, can exacerbate sleep disturbances in patients.

Additionally, treatment-related side effects like nausea and vomiting further compound these issues, making sleep management a crucial aspect of cancer care.

Dr. M A Raja, Director and Senior Consultant at MGM Cancer Institute in Chennai emphasized that sleep disorders like insomnia increase the risk and worsen the prognosis of breast and ovarian cancers.

He noted that sleep is crucial for the body, being involved in endocrine, metabolic, and immunoregulatory pathways, which are linked to various cancers.

Insomnia can also lead to poorer mental health, indirectly affecting treatment adherence and overall well-being during cancer therapy.

Understanding this connection underscores the importance of addressing sleep disturbances in cancer care.

“Developing tailored interventions like cognitive behavioral therapy for insomnia could enhance outcomes for ovarian cancer patients by fostering improved sleep and fortifying resilience against the disease,” Dr. Kinjal suggested to IANS.

Also Read: Snoring Poses Significant Health Risks, Experts Warn